Uterine Neoplasms Clinical Trial
Official title:
A Pilot Study of Conformal Intensity Modulated Radiation Therapy (IMRT) for Gynaecological Cancer Patients Not Suitable for Intracavitary Brachytherapy Boost (GY03.2)
Standard treatment for gynecological cancer is radiation therapy in two phases; whole pelvic
radiation and then an internal radiation boost, also called a brachytherapy boost, to treat
any remaining tumour.
The purpose of this study is to test an alternative radiation boost treatment called
conformal intensity modulated radiation therapy or IMRT. Currently, we do not have complete
information on the overall effectiveness of IMRT compared to brachytherapy or conformal
radiotherapy. We know that IMRT allows the radiation beams to be more accurately focused on
the tumor, thereby sparing more normal tissue from radiation damage and lowering risks of
side effects. We are investigating the extent to which IMRT can be used to protect normal
tissues in patients with cervix, uterine or vaginal cancer from the radiation beams and how
much the side effects of radiation are reduced.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02374411 -
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
|
N/A | |
| Completed |
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
| Recruiting |
NCT04063072 -
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.
|
N/A | |
| Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
| Terminated |
NCT00669422 -
ChemoFx® PRO - A Post-Market Data Collection Study
|
N/A | |
| Recruiting |
NCT01564264 -
Sentinel Node Biopsy in Endometrial Cancer
|
N/A | |
| Completed |
NCT00231855 -
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
|
Phase 2 | |
| Completed |
NCT04679675 -
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
|
N/A | |
| Completed |
NCT04351139 -
Impact of the COVID-19 Pandemic in Gynecological Oncology
|
||
| Completed |
NCT05004623 -
Early Feasibility Study of the "Easy Light" Fluorecence Imaging System
|
N/A | |
| Completed |
NCT00112307 -
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
|
N/A | |
| Completed |
NCT02454036 -
Biobehavioral Intervention in Gynecologic Oncology Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03951415 -
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
|
Phase 2 | |
| Completed |
NCT01654458 -
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
|
N/A | |
| Completed |
NCT00190918 -
A Trial for Patients With Gestational Trophoblastic Disease
|
Phase 2 | |
| Completed |
NCT00250783 -
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
|
||
| Completed |
NCT00050440 -
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
|
Phase 2 | |
| Recruiting |
NCT03624712 -
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
|
||
| Completed |
NCT00628901 -
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
|
Phase 4 | |
| Completed |
NCT00090389 -
Acupuncture for Women's Health Conditions
|
Phase 1 |